Skip to main content

Translational Neurodegeneration

Ausgabe 1/2022

Inhalt (58 Artikel)

Open Access Research

Neddylation-dependent protein degradation is a nexus between synaptic insulin resistance, neuroinflammation and Alzheimer’s disease

Alessandro Dario Confettura, Eleonora Cuboni, Mohamed Rafeet Ammar, Shaobo Jia, Guilherme M. Gomes, PingAn Yuanxiang, Rajeev Raman, Tingting Li, Katarzyna M. Grochowska, Robert Ahrends, Anna Karpova, Alexander Dityatev, Michael R. Kreutz

Open Access Review

Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration

Manish Verma, Britney N. Lizama, Charleen T. Chu

Open Access Review

Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential

Lina Gao, Yun Zhang, Keenan Sterling, Weihong Song

Open Access Review

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease

Shirley Yin-Yu Pang, Rachel Cheuk Nam Lo, Philip Wing-Lok Ho, Hui-Fang Liu, Eunice Eun Seo Chang, Chi-Ting Leung, Yasine Malki, Zoe Yuen-Kiu Choi, Wing Yan Wong, Michelle Hiu-Wai Kung, David Boyer Ramsden, Shu-Leong Ho

Open Access Research

Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson’s disease patients

Gen Li, Pei Huang, Shi-Shuang Cui, Yu-Yan Tan, Ya-Chao He, Xin Shen, Qin-Ying Jiang, Ping Huang, Gui-Ying He, Bin-Yin Li, Yu-Xin Li, Jin Xu, Zheng Wang, Sheng-Di Chen

Open Access Research

Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

Ivan Martinez-Valbuena, Naomi P. Visanji, Ain Kim, Heather H. C. Lau, Raphaella W. L. So, Sohaila Alshimemeri, Andrew Gao, Michael A. Seidman, Maria R. Luquin, Joel C. Watts, Anthony E. Lang, Gabor G. Kovacs

Open Access Research

EEG/ERP evidence of possible hyperexcitability in older adults with elevated beta-amyloid

Hannes Devos, Kathleen Gustafson, Ke Liao, Pedram Ahmadnezhad, Bradley Estes, Laura E. Martin, Jonathan D. Mahnken, William M. Brooks, Jeffrey M. Burns

Open Access Research

Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease

Elisabet Jakova, Mohamed Taha Moutaoufik, Jeremy S. Lee, Mohan Babu, Francisco S. Cayabyab

Open Access Review

LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease

Eunice Eun Seo Chang, Philip Wing-Lok Ho, Hui-Fang Liu, Shirley Yin-Yu Pang, Chi-Ting Leung, Yasine Malki, Zoe Yuen-Kiu Choi, David Boyer Ramsden, Shu-Leong Ho

Open Access Review

Prodromal Parkinson's disease: hype or hope for disease-modification trials?

Philipp Mahlknecht, Kathrin Marini, Mario Werkmann, Werner Poewe, Klaus Seppi

Open Access Research highlight

RNA targets of TDP-43: Which one is more important in neurodegeneration?

Dilara Halim, Fen-Biao Gao

Open Access Research

Clinical and genetic characterization of a large cohort of patients with Wilson’s disease in China

Shijie Zhang, Wenming Yang, Xiang Li, Pei Pei, Ting Dong, Yue Yang, Jing Zhang

Open Access Research

Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model

Yi-Qing Lv, Lin Yuan, Yan Sun, Hao-Wen Dou, Ji-Hui Su, Zhi-Pan Hou, Jia-Yi Li, Wen Li

Open Access Research

Autologous treatment for ALS with implication for broad neuroprotection

Daehwan Kim, Subin Kim, Ashley Sung, Neetika Patel, Nathan Wong, Michael J. Conboy, Irina M. Conboy

Open Access Research

Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis

Akram Zamani, Adam K. Walker, Ben Rollo, Katie L. Ayers, Raysha Farah, Terence J. O’Brien, David K. Wright

Open Access Review

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond

Chenghuan Song, Jiyun Shi, Pingao Zhang, Yongfang Zhang, Jianrong Xu, Lanxue Zhao, Rui Zhang, Hao Wang, Hongzhuan Chen

Open Access Review

Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system

Douglas M. Lopes, Sophie K. Llewellyn, Ian F. Harrison

Open Access Research

α-Synuclein arginylation in the human brain

Jun Zhao, Buyan Pan, Marie Fina, Yun Huang, Marie Shimogawa, Kelvin C. Luk, Elizabeth Rhoades, E. James Petersson, Dawei W. Dong, Anna Kashina

Open Access Review

Genetic heterogeneity on sleep disorders in Parkinson’s disease: a systematic review and meta-analysis

Jingxuan Huang, Yangfan Cheng, Chunyu Li, Huifang Shang

Open Access Research

Analysis of human brain tissue derived from DBS surgery

Salla M. Kangas, Jaakko Teppo, Maija J. Lahtinen, Anu Suoranta, Bishwa Ghimire, Pirkko Mattila, Johanna Uusimaa, Markku Varjosalo, Jani Katisko, Reetta Hinttala

Open Access Review

Stepping up to meet the challenge of freezing of gait in Parkinson’s disease

Simon Lewis, Stewart Factor, Nir Giladi, Alice Nieuwboer, John Nutt, Mark Hallett

Open Access Review

Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Federico Rodriguez-Porcel, Kathryn A. Wyman-Chick, Carla Abdelnour Ruiz, Jon B. Toledo, Daniel Ferreira, Prabitha Urwyler, Rimona S. Weil, Joseph Kane, Andrea Pilotto, Arvid Rongve, Bradley Boeve, John-Paul Taylor, Ian McKeith, Dag Aarsland, Simon J. G. Lewis

Open Access Review

Advances in the development of new biomarkers for Alzheimer’s disease

Timofey O. Klyucherev, Pawel Olszewski, Alena A. Shalimova, Vladimir N. Chubarev, Vadim V. Tarasov, Misty M. Attwood, Stina Syvänen, Helgi B. Schiöth

Open Access Research

Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease

Christopher Daniel Morrone, Aaron Yenhsin Lai, Jossana Bishay, Mary Elizabeth Hill, JoAnne McLaurin

Open Access Research

Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease

Dongmei Chen, Guihua Lan, Ruomeng Li, Yingxue Mei, Xindong Shui, Xi Gu, Long Wang, Tao Zhang, Chen-Ling Gan, Yongfang Xia, Li Hu, Yuan Tian, Mi Zhang, Tae Ho Lee

Open Access Review

A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin

Neelam Younas, Leticia Camila Fernandez Flores, Franziska Hopfner, Günter U. Höglinger, Inga Zerr

Open Access Correction

Correction: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

Federico Rodriguez-Porcel, Kathryn A. Wyman-Chick, Carla Abdelnour Ruiz, Jon B. Toledo, Daniel Ferreira, Prabitha Urwyler, Rimona S. Weil, Joseph Kane, Andrea Pilotto, Arvid Rongve, Bradley Boeve, John-Paul Taylor, Ian McKeith, Dag Aarsland, Simon J. G. Lewis

Open Access Research

N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology

Agueda Rostagno, Erwin Cabrera, Tammaryn Lashley, Jorge Ghiso

Open Access Research

Impaired dynamic interaction of axonal endoplasmic reticulum and ribosomes contributes to defective stimulus–response in spinal muscular atrophy

Chunchu Deng, Sebastian Reinhard, Luisa Hennlein, Janna Eilts, Stefan Sachs, Sören Doose, Sibylle Jablonka, Markus Sauer, Mehri Moradi, Michael Sendtner

Open Access Review

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease

Kuan Zeng, Xuan Yu, Yacoubou Abdoul Razak Mahaman, Jian-Zhi Wang, Rong Liu, Yi Li, Xiaochuan Wang

Open Access Review

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases

Kareem Khalaf, Paolo Tornese, Antoniangela Cocco, Alberto Albanese

Open Access Research

Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy

Scott C. Vermilyea, Anne Christensen, Joyce Meints, Balvindar Singh, Héctor Martell-Martínez, Md. Razaul Karim, Michael K. Lee

Open Access Retraction Note

Retraction Note: Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease

Haichen Niu, Lingyu Shen, Tongzhou Li, Chao Ren, Sheng Ding, Lei Wang, Zhonghai Zhang, Xiaoyu Liu, Qiang Zhang, Deqin Geng, Xiujuan Wu, Haiying Li

Open Access Review

The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders

Margrethe A. Olesen, Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla

Open Access Research

Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Matilde Bongianni, Mauro Catalan, Daniela Perra, Elena Fontana, Francesco Janes, Claudio Bertolotti, Luca Sacchetto, Stefano Capaldi, Matteo Tagliapietra, Paola Polverino, Valentina Tommasini, Giulia Bellavita, Elham Ataie Kachoie, Roberto Baruca, Andrea Bernardini, Mariarosaria Valente, Michele Fiorini, Erika Bronzato, Stefano Tamburin, Laura Bertolasi, Lorenzo Brozzetti, Maria Paola Cecchini, Gianluigi Gigli, Salvatore Monaco, Paolo Manganotti, Gianluigi Zanusso

Open Access Correction

Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease

Matilde Bongianni, Mauro Catalan, Daniela Perra, Elena Fontana, Francesco Janes, Claudio Bertolotti, Luca Sacchetto, Stefano Capaldi, Matteo Tagliapietra, Paola Polverino, Valentina Tommasini, Giulia Bellavita, Elham Ataie Kachoie, Roberto Baruca, Andrea Bernardini, Mariarosaria Valente, Michele Fiorini, Erika Bronzato, Stefano Tamburin, Laura Bertolasi, Lorenzo Brozzetti, Maria Paola Cecchini, Gianluigi Gigli, Salvatore Monaco, Paolo Manganotti, Gianluigi Zanusso

Open Access Review

The emerging role of furin in neurodegenerative and neuropsychiatric diseases

Yi Zhang, Xiaoqin Gao, Xue Bai, Shanshan Yao, Yan-Zhong Chang, Guofen Gao

Open Access COVID-19 Review

The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms

Feng Chen, Yanting Chen, Yongxiang Wang, Qiongwei Ke, Lili Cui

Open Access Research

CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer’s disease

Hanseul Park, Jaein Shin, Yunkyung Kim, Takashi Saito, Takaomi C. Saido, Jongpil Kim

Open Access Review

A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives

Lanlan Li, Xianfeng Yu, Can Sheng, Xueyan Jiang, Qi Zhang, Ying Han, Jiehui Jiang

Open Access Review

Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?

Silvia Rota, Daniele Urso, Daniel J. van Wamelen, Valentina Leta, Iro Boura, Per Odin, Alberto J. Espay, Peter Jenner, K. Ray Chaudhuri

Open Access Research

APOE ε4-dependent effects on the early amyloid pathology in induced neurons of patients with Alzheimer’s disease

Hongwon Kim, Siyoung Kim, Byounggook Cho, Jaein Shin, Jongpil Kim

Open Access Research

Association of variants in the KIF1A gene with amyotrophic lateral sclerosis

Panlin Liao, Yanchun Yuan, Zhen Liu, Xiaorong Hou, Wanzhen Li, Jin Wen, Kexuan Zhang, Bin Jiao, Lu Shen, Hong Jiang, Jifeng Guo, Beisha Tang, Zhuohua Zhang, Zhonghua Hu, Junling Wang

Open Access Review

Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics

Lauren Rose Hirschfeld, Shannon L. Risacher, Kwangsik Nho, Andrew J. Saykin

Open Access Review

Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine

Ira Agrawal, Yong Shan Lim, Shi-Yan Ng, Shuo-Chien Ling

Open Access Research

Gut microbiome, cognitive function and brain structure: a multi-omics integration analysis

Xinxiu Liang, Yuanqing Fu, Wen-ting Cao, Zhihong Wang, Ke Zhang, Zengliang Jiang, Xiaofang Jia, Chun-ying Liu, Hong-rou Lin, Haili Zhong, Zelei Miao, Wanglong Gou, Menglei Shuai, Yujing Huang, Shengdi Chen, Bing Zhang, Yu-ming Chen, Ju-Sheng Zheng

Open Access Research

Deep brain stimulation of the nucleus basalis of Meynert modulates hippocampal–frontoparietal networks in patients with advanced Alzheimer’s disease

Yin Jiang, Tian-Shuo Yuan, Ying-Chuan Chen, Peng Guo, Teng-Hong Lian, Yu-Ye Liu, Wei Liu, Yu-Tong Bai, Quan Zhang, Wei Zhang, Jian-Guo Zhang

Open Access Research

Axonal degeneration in the anterior insular cortex is associated with Alzheimer’s co-pathology in Parkinson’s disease and dementia with Lewy bodies

Yasmine Y. Fathy, Laura E. Jonkman, John J. Bol, Evelien Timmermans, Allert J. Jonker, Annemieke J. M. Rozemuller, Wilma D. J. van de Berg

Open Access Review

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases

Xiaohuan Xia, Yi Wang, Jialin C. Zheng

Open Access Research

ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein

Gillian Bonvicini, Stina Syvänen, Ken G. Andersson, Merja Haaparanta-Solin, Francisco López-Picón, Dag Sehlin

Open Access Review

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis

Sarah Lépine, Maria José Castellanos-Montiel, Thomas Martin Durcan

Open Access Research

Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model

Chanho Kong, Eun-Jeong Yang, Jaewoo Shin, Junwon Park, Si-Hyun Kim, Seong-Wook Park, Won Seok Chang, Chang-Han Lee, Hyunju Kim, Hye-Sun Kim, Jin Woo Chang

Open Access Research

Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology

Ankit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, Srinivas Pittala, Avijit Paul, Edna Nahon Crystal, Alberto Ouro, Vered Chalifa-Caspi, Swaroop Kumar Pandey, Alon Monsonego, Noga Vardi, Shira Knafo, Varda Shoshan-Barmatz

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.